|
GATAD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.68798350034194E-13 |
| Normal-vs-Stage2 |
4.152400E-02 |
| Normal-vs-Stage3 |
1.194110E-02 |
| Normal-vs-Stage4 |
3.085500E-02 |
| Stage1-vs-Stage2 |
3.388800E-01 |
| Stage1-vs-Stage3 |
1.122350E-01 |
| Stage1-vs-Stage4 |
7.210000E-01 |
| Stage2-vs-Stage3 |
1.542240E-01 |
| Stage2-vs-Stage4 |
2.849400E-01 |
| Stage3-vs-Stage4 |
4.617600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.015890E-03 |
| Normal-vs-Asian |
5.86760000031994E-07 |
| Caucasian-vs-AfricanAmerican |
8.793600E-01 |
| Caucasian-vs-Asian |
3.711900E-02 |
| AfricanAmerican-vs-Asian |
2.835200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
5.964600E-04 |
| Male-vs-Female |
4.565200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.22879999999259E-05 |
| Normal-vs-Extreme_Weight |
2.41279995982779E-09 |
| Normal-vs-Obese |
1.178210E-04 |
| Normal-vs-Extreme_Obese |
8.097600E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.239400E-01 |
| Normal_Weight-vs-Obese |
3.049400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.725400E-01 |
| Extreme_Weight-vs-Obese |
6.505800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.636400E-01 |
| Obese-vs-Extreme_Obese |
5.680200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.878800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.10460000035673E-08 |
| Normal-vs-Age(81-100Yrs) |
1.325990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.827200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.715600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.489000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.629000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.323800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.728800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
3.416100E-03 |
| Normal-VS-KIRP CIMP |
4.007800E-01 |
| Normal-VS-Unclassified PRCC |
2.300500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.68549676624752E-11 |
| Type1 PRCC-VS-KIRP CIMP |
1.825400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.323990E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.322800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.424230E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.359800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.366650E-04 |
| Normal-vs-N1 |
5.376400E-03 |
| Normal-vs-N2 |
3.568400E-01 |
| N0-vs-N1 |
6.431200E-01 |
| N0-vs-N2 |
5.067200E-01 |
| N1-vs-N2 |
5.686600E-01 |
|
|
